FDA-Approved a step towards treatment for Alzheimer’s disease Updated: Aug. 3, 2024 at 5:58 AM GMT+8 | ByABC7 Staff FDA has approved Kisunla (donanemab-azbt), an amyloid therapy for early stages of Alzheimer’s disease. As Seen On 7 ...